SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-035203
Filing Date
2024-02-14
Accepted
2024-02-14 08:35:01
Documents
19
Period of Report
2024-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d790187d8k.htm   iXBRL 8-K 38145
2 EX-3.1 d790187dex31.htm EX-3.1 66006
3 EX-10.1 d790187dex101.htm EX-10.1 352981
4 EX-10.2 d790187dex102.htm EX-10.2 170516
5 EX-99.1 d790187dex991.htm EX-99.1 12901
9 GRAPHIC g790187g91r78.jpg GRAPHIC 9035
  Complete submission text file 0001193125-24-035203.txt   912862

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cogt-20240213.xsd EX-101.SCH 2856
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cogt-20240213_lab.xml EX-101.LAB 18739
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cogt-20240213_pre.xml EX-101.PRE 11711
20 EXTRACTED XBRL INSTANCE DOCUMENT d790187d8k_htm.xml XML 3832
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38443 | Film No.: 24632603
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)